In an era where precision medicine and individualized healthcare are revolutionizing clinical practice, comprehending genetic variations has become increasingly important for enhancing human health. This authoritative volume examines the advances in methods for unraveling the causalities of genetic variations and cytogenetics, providing readers with a detailed analysis of powerful analytical methods that assess causal relationships, and how changes in DNA sequence, ranging from single-nucleotide polymorphisms to intricate chromosomal rearrangements, affect susceptibility to disease, responses to therapy, and population health outcomes. The book conjoins fundamental genetic concepts with methodological breakthroughs, including Mendelian randomization, next-generation sequencing, polygenic risk scoring, and high-performance computational genomics. The reader will discover how new approaches are revolutionizing the diagnosis of microdeletion syndrome, enabling accurate genotype-phenotype correlations that guide clinical decision-making. The book integrates concepts from population genetics and evolutionary biology in a unique way to explain how natural selection and migration gradients have shaped current genetic diversity and disease resistance mechanisms. Special emphasis is placed on emerging methodologies, such as Environmental Pollutant-based Polygenic Risk Scores and Mendelian randomization approaches, that develop novel paradigms in gene-environment interactions. From antibiotic resistance mechanisms to cancer susceptibility risk factors, the book provides insightful critical examinations of how genetic research is addressing contemporary public health challenges. The convergence of artificial intelligence and machine learning technologies is a sign of the future direction of gene research and the identification of therapeutic targets. This book is essential for researchers, clinicians, and graduate students who want to understand the complex relationship between genetic variation and human disease. It highlights ethical considerations and the appropriate use of genetic medicine within diverse, global populations.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In an era where precision medicine and individualized healthcare are revolutionizing clinical practice, comprehending genetic variations has become increasingly important for enhancing human health. This authoritative volume examines the advances in methods for unraveling the causalities of genetic variations and cytogenetics, providing readers with a detailed analysis of powerful analytical methods that assess causal relationships, and how changes in DNA sequence, ranging from single-nucleotide polymorphisms to intricate chromosomal rearrangements, affect susceptibility to disease, responses to therapy, and population health outcomes. The book conjoins fundamental genetic concepts with methodological breakthroughs, including Mendelian randomization, next-generation sequencing, polygenic risk scoring, and high-performance computational genomics. The reader will discover how new approaches are revolutionizing the diagnosis of microdeletion syndrome, enabling accurate genotype-phenotype correlations that guide clinical decision-making. The book integrates concepts from population genetics and evolutionary biology in a unique way to explain how natural selection and migration gradients have shaped current genetic diversity and disease resistance mechanisms. Special emphasis is placed on emerging methodologies, such as Environmental Pollutant-based Polygenic Risk Scores and Mendelian randomization approaches, that develop novel paradigms in gene-environment interactions. From antibiotic resistance mechanisms to cancer susceptibility risk factors, the book provides insightful critical examinations of how genetic research is addressing contemporary public health challenges. The convergence of artificial intelligence and machine learning technologies is a sign of the future direction of gene research and the identification of therapeutic targets. This book is essential for researchers, clinicians, and graduate students who want to understand the complex relationship between genetic variation and human disease. It highlights ethical considerations and the appropriate use of genetic medicine within diverse, global populations. 184 pp. Englisch. N° de réf. du vendeur 9781837699032
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In an era where precision medicine and individualized healthcare are revolutionizing clinical practice, comprehending genetic variations has become increasingly important for enhancing human health. This authoritative volume examines the advances in methods for unraveling the causalities of genetic variations and cytogenetics, providing readers with a detailed analysis of powerful analytical methods that assess causal relationships, and how changes in DNA sequence, ranging from single-nucleotide polymorphisms to intricate chromosomal rearrangements, affect susceptibility to disease, responses to therapy, and population health outcomes. The book conjoins fundamental genetic concepts with methodological breakthroughs, including Mendelian randomization, next-generation sequencing, polygenic risk scoring, and high-performance computational genomics. The reader will discover how new approaches are revolutionizing the diagnosis of microdeletion syndrome, enabling accurate genotype-phenotype correlations that guide clinical decision-making. The book integrates concepts from population genetics and evolutionary biology in a unique way to explain how natural selection and migration gradients have shaped current genetic diversity and disease resistance mechanisms. Special emphasis is placed on emerging methodologies, such as Environmental Pollutant-based Polygenic Risk Scores and Mendelian randomization approaches, that develop novel paradigms in gene-environment interactions. From antibiotic resistance mechanisms to cancer susceptibility risk factors, the book provides insightful critical examinations of how genetic research is addressing contemporary public health challenges. The convergence of artificial intelligence and machine learning technologies is a sign of the future direction of gene research and the identification of therapeutic targets. This book is essential for researchers, clinicians, and graduate students who want to understand the complex relationship between genetic variation and human disease. It highlights ethical considerations and the appropriate use of genetic medicine within diverse, global populations. N° de réf. du vendeur 9781837699032
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -In an era where precision medicine and individualized healthcare are revolutionizing clinical practice, comprehending genetic variations has become increasingly important for enhancing human health. This authoritative volume examines the advances in methods for unraveling the causalities of genetic variations and cytogenetics, providing readers with a detailed analysis of powerful analytical methods that assess causal relationships, and how changes in DNA sequence, ranging from single-nucleotide polymorphisms to intricate chromosomal rearrangements, affect susceptibility to disease, responses to therapy, and population health outcomes. The book conjoins fundamental genetic concepts with methodological breakthroughs, including Mendelian randomization, next-generation sequencing, polygenic risk scoring, and high-performance computational genomics. The reader will discover how new approaches are revolutionizing the diagnosis of microdeletion syndrome, enabling accurate genotype-phenotype correlations that guide clinical decision-making. The book integrates concepts from population genetics and evolutionary biology in a unique way to explain how natural selection and migration gradients have shaped current genetic diversity and disease resistance mechanisms. Special emphasis is placed on emerging methodologies, such as Environmental Pollutant-based Polygenic Risk Scores and Mendelian randomization approaches, that develop novel paradigms in gene-environment interactions. From antibiotic resistance mechanisms to cancer susceptibility risk factors, the book provides insightful critical examinations of how genetic research is addressing contemporary public health challenges. The convergence of artificial intelligence and machine learning technologies is a sign of the future direction of gene research and the identification of therapeutic targets. This book is essential for researchers, clinicians, and graduate students who want to understand the complex relationship between genetic variation and human disease. It highlights ethical considerations and the appropriate use of genetic medicine within diverse, global populations.Books on Demand GmbH, Überseering 33, 22297 Hamburg 184 pp. Englisch. N° de réf. du vendeur 9781837699032
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Buch. Etat : Neu. Unraveling the Causalities of Genetic Variations - Recent Advances in Cytogenetics | Recent Advances in Cytogenetics | Buch | Englisch | 2025 | IntechOpen | EAN 9781837699032 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 134396439
Quantité disponible : 5 disponible(s)